SAMN38144174
External Id
dbGaP
INSDC center name
2023-11-07T12:13:16.737Z
INSDC first public
2024-05-30T05:48:20.403Z
INSDC last update
SRS19518553
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS19518553
SRA accession
NCI_Pembrolizumab_MIBC
biospecimen repository
patient_116_Tumor_Pre_RNA-Seq
biospecimen repository sample id
Urinary Bladder Tumor
body site
phs003452
gap_accession
1
gap_consent_code
DS-CA
gap_consent_short_name
5699524
gap_sample_id
4644995
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Case Set
study design
Urinary Bladder Neoplasms
study disease
Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy
study name
Yes
subject is affected
patient_116_Tumor_Pre_RNA-Seq
submitted sample id
patient_116
submitted subject id
NCI_Pembrolizumab_MIBC
submitter handle
Urinary Bladder Neoplasms tumor sample from Urinary Bladder Tumor of a human male participant in the dbGaP study "Phase 2 Study of Pembrolizumab in Combination with Gemcitabine and Cisplatin as Neoadjuvant Therapy"
title